ID   PURA1_HUMAN             Reviewed;         457 AA.
AC   Q8N142; Q86TT6; Q8N714;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   07-APR-2021, entry version 171.
DE   RecName: Full=Adenylosuccinate synthetase isozyme 1 {ECO:0000255|HAMAP-Rule:MF_03126};
DE            Short=AMPSase 1 {ECO:0000255|HAMAP-Rule:MF_03126};
DE            Short=AdSS 1 {ECO:0000255|HAMAP-Rule:MF_03126};
DE            EC=6.3.4.4 {ECO:0000255|HAMAP-Rule:MF_03126, ECO:0000269|PubMed:26506222};
DE   AltName: Full=Adenylosuccinate synthetase, basic isozyme {ECO:0000255|HAMAP-Rule:MF_03126};
DE   AltName: Full=Adenylosuccinate synthetase, muscle isozyme {ECO:0000255|HAMAP-Rule:MF_03126};
DE            Short=M-type adenylosuccinate synthetase {ECO:0000255|HAMAP-Rule:MF_03126};
DE   AltName: Full=Adenylosuccinate synthetase-like 1 {ECO:0000303|PubMed:15786719};
DE            Short=AdSSL1 {ECO:0000303|PubMed:15786719};
DE   AltName: Full=IMP--aspartate ligase 1 {ECO:0000255|HAMAP-Rule:MF_03126};
GN   Name=ADSS1 {ECO:0000312|HGNC:HGNC:20093};
GN   Synonyms=ADSSL1 {ECO:0000255|HAMAP-Rule:MF_03126};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Bone marrow stroma;
RX   PubMed=15786719; DOI=10.1007/s11010-005-2539-9;
RA   Sun H., Li N., Wang X., Chen T., Shi L., Zhang L., Wang J., Wan T., Cao X.;
RT   "Molecular cloning and characterization of a novel muscle adenylosuccinate
RT   synthetase, AdSSL1, from human bone marrow stromal cells.";
RL   Mol. Cell. Biochem. 269:85-94(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, INVOLVEMENT IN MPD5, VARIANT MPD5
RP   ASN-261, AND CHARACTERIZATION OF VARIANT MPD5 ASN-261.
RX   PubMed=26506222; DOI=10.1002/ana.24550;
RA   Park H.J., Hong Y.B., Choi Y.C., Lee J., Kim E.J., Lee J.S., Mo W.M.,
RA   Ki S.M., Kim H.I., Kim H.J., Hyun Y.S., Hong H.D., Nam K., Jung S.C.,
RA   Kim S.B., Kim S.H., Kim D.H., Oh K.W., Kim S.H., Yoo J.H., Lee J.E.,
RA   Chung K.W., Choi B.O.;
RT   "ADSSL1 mutation relevant to autosomal recessive adolescent onset distal
RT   myopathy.";
RL   Ann. Neurol. 79:231-243(2016).
CC   -!- FUNCTION: Component of the purine nucleotide cycle (PNC), which
CC       interconverts IMP and AMP to regulate the nucleotide levels in various
CC       tissues, and which contributes to glycolysis and ammoniagenesis.
CC       Catalyzes the first committed step in the biosynthesis of AMP from IMP.
CC       {ECO:0000269|PubMed:26506222}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + IMP + L-aspartate = GDP + 2 H(+) + N(6)-(1,2-
CC         dicarboxyethyl)-AMP + phosphate; Xref=Rhea:RHEA:15753,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29991, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57567, ChEBI:CHEBI:58053,
CC         ChEBI:CHEBI:58189; EC=6.3.4.4; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_03126, ECO:0000269|PubMed:26506222};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03126};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000255|HAMAP-Rule:MF_03126};
CC   -!- PATHWAY: Purine metabolism; AMP biosynthesis via de novo pathway; AMP
CC       from IMP: step 1/2. {ECO:0000255|HAMAP-Rule:MF_03126,
CC       ECO:0000269|PubMed:26506222}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_03126}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03126,
CC       ECO:0000269|PubMed:15786719}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N142-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N142-2; Sequence=VSP_008421;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in skeletal muscle and
CC       heart, as well as in several hematopoietic cell lines and solid tumors.
CC       {ECO:0000269|PubMed:15786719}.
CC   -!- DISEASE: Myopathy, distal, 5 (MPD5) [MIM:617030]: A form of distal
CC       myopathy, a group of muscular disorders characterized by progressive
CC       muscular weakness and muscle atrophy beginning in the hands, the legs
CC       or the feet. MPD5 is an autosomal recessive form, predominantly
CC       affecting the lower limbs. {ECO:0000269|PubMed:26506222}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the adenylosuccinate synthetase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03126}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH32039.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAD62614.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY037159; AAK67646.1; -; mRNA.
DR   EMBL; AK095921; BAC04649.1; -; mRNA.
DR   EMBL; BX248286; CAD62614.1; ALT_INIT; mRNA.
DR   EMBL; BC032039; AAH32039.1; ALT_FRAME; mRNA.
DR   EMBL; BC047904; AAH47904.1; -; mRNA.
DR   CCDS; CCDS9990.1; -. [Q8N142-1]
DR   CCDS; CCDS9991.1; -. [Q8N142-2]
DR   RefSeq; NP_001307353.1; NM_001320424.1.
DR   RefSeq; NP_689541.1; NM_152328.4. [Q8N142-1]
DR   RefSeq; NP_954634.1; NM_199165.2. [Q8N142-2]
DR   PDB; 2GJO; Model; -; A=27-457.
DR   PDBsum; 2GJO; -.
DR   SMR; Q8N142; -.
DR   BioGRID; 125783; 5.
DR   IntAct; Q8N142; 5.
DR   MINT; Q8N142; -.
DR   STRING; 9606.ENSP00000333019; -.
DR   DrugBank; DB03510; 6-O-Phosphoryl Inosine Monophosphate.
DR   DrugBank; DB00787; Acyclovir.
DR   DrugBank; DB04418; Adenylosuccinic acid.
DR   DrugBank; DB05540; Alanosine.
DR   DrugBank; DB00128; Aspartic acid.
DR   DrugBank; DB04315; Guanosine-5'-Diphosphate.
DR   DrugBank; DB04137; Guanosine-5'-Triphosphate.
DR   DrugBank; DB02109; Hadacidin.
DR   DrugBank; DB04566; Inosinic Acid.
DR   iPTMnet; Q8N142; -.
DR   PhosphoSitePlus; Q8N142; -.
DR   BioMuta; ADSSL1; -.
DR   DMDM; 37537958; -.
DR   EPD; Q8N142; -.
DR   jPOST; Q8N142; -.
DR   MassIVE; Q8N142; -.
DR   MaxQB; Q8N142; -.
DR   PaxDb; Q8N142; -.
DR   PeptideAtlas; Q8N142; -.
DR   PRIDE; Q8N142; -.
DR   ProteomicsDB; 71550; -. [Q8N142-1]
DR   ProteomicsDB; 71551; -. [Q8N142-2]
DR   Antibodypedia; 28209; 99 antibodies.
DR   Ensembl; ENST00000330877; ENSP00000331260; ENSG00000185100. [Q8N142-1]
DR   Ensembl; ENST00000332972; ENSP00000333019; ENSG00000185100. [Q8N142-2]
DR   GeneID; 122622; -.
DR   KEGG; hsa:122622; -.
DR   UCSC; uc001ypd.5; human. [Q8N142-1]
DR   CTD; 122622; -.
DR   DisGeNET; 122622; -.
DR   GeneCards; ADSS1; -.
DR   HGNC; HGNC:20093; ADSS1.
DR   HPA; ENSG00000185100; Group enriched (skeletal muscle, tongue).
DR   MalaCards; ADSS1; -.
DR   MIM; 612498; gene.
DR   MIM; 617030; phenotype.
DR   neXtProt; NX_Q8N142; -.
DR   OpenTargets; ENSG00000185100; -.
DR   Orphanet; 482601; Adenylosuccinate synthetase-like 1-related distal myopathy.
DR   PharmGKB; PA134974111; -.
DR   VEuPathDB; HostDB:ENSG00000185100.10; -.
DR   eggNOG; KOG1355; Eukaryota.
DR   GeneTree; ENSGT00390000015553; -.
DR   HOGENOM; CLU_029848_0_0_1; -.
DR   InParanoid; Q8N142; -.
DR   OMA; RQHQSMF; -.
DR   OrthoDB; 1276527at2759; -.
DR   PhylomeDB; Q8N142; -.
DR   TreeFam; TF300486; -.
DR   BRENDA; 6.3.4.4; 2681.
DR   PathwayCommons; Q8N142; -.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   UniPathway; UPA00075; UER00335.
DR   BioGRID-ORCS; 122622; 6 hits in 993 CRISPR screens.
DR   ChiTaRS; ADSSL1; human.
DR   GenomeRNAi; 122622; -.
DR   Pharos; Q8N142; Tbio.
DR   PRO; PR:Q8N142; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q8N142; protein.
DR   Bgee; ENSG00000185100; Expressed in quadriceps femoris and 202 other tissues.
DR   ExpressionAtlas; Q8N142; baseline and differential.
DR   Genevisible; Q8N142; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0004019; F:adenylosuccinate synthase activity; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; NAS:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0042301; F:phosphate ion binding; NAS:UniProtKB.
DR   GO; GO:0044208; P:'de novo' AMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006167; P:AMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006531; P:aspartate metabolic process; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:Ensembl.
DR   GO; GO:0002376; P:immune system process; NAS:UniProtKB.
DR   GO; GO:0046040; P:IMP metabolic process; IBA:GO_Central.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   GO; GO:0014850; P:response to muscle activity; IEA:Ensembl.
DR   GO; GO:0042594; P:response to starvation; IEA:Ensembl.
DR   CDD; cd03108; AdSS; 1.
DR   Gene3D; 1.10.300.10; -; 1.
DR   Gene3D; 3.40.440.10; -; 1.
DR   Gene3D; 3.90.170.10; -; 1.
DR   HAMAP; MF_00011; Adenylosucc_synth; 1.
DR   HAMAP; MF_03126; Adenylosucc_synth_vert_basic; 1.
DR   InterPro; IPR018220; Adenylosuccin_syn_GTP-bd.
DR   InterPro; IPR033128; Adenylosuccin_syn_Lys_AS.
DR   InterPro; IPR042109; Adenylosuccinate_synth_dom1.
DR   InterPro; IPR042110; Adenylosuccinate_synth_dom2.
DR   InterPro; IPR042111; Adenylosuccinate_synth_dom3.
DR   InterPro; IPR001114; Adenylosuccinate_synthetase.
DR   InterPro; IPR027509; AdSS_1_vert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11846; PTHR11846; 1.
DR   Pfam; PF00709; Adenylsucc_synt; 1.
DR   SMART; SM00788; Adenylsucc_synt; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00184; purA; 1.
DR   PROSITE; PS01266; ADENYLOSUCCIN_SYN_1; 1.
DR   PROSITE; PS00513; ADENYLOSUCCIN_SYN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Disease variant;
KW   GTP-binding; Ligase; Magnesium; Metal-binding; Nucleotide-binding;
KW   Purine biosynthesis; Reference proteome.
FT   CHAIN           1..457
FT                   /note="Adenylosuccinate synthetase isozyme 1"
FT                   /id="PRO_0000095132"
FT   NP_BIND         42..48
FT                   /note="GTP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   NP_BIND         70..72
FT                   /note="GTP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   NP_BIND         363..365
FT                   /note="GTP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   NP_BIND         445..448
FT                   /note="GTP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   REGION          43..46
FT                   /note="IMP binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   REGION          68..71
FT                   /note="IMP binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   REGION          331..337
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   ACT_SITE        43
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   ACT_SITE        71
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   METAL           43
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   METAL           70
FT                   /note="Magnesium; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   BINDING         43
FT                   /note="Substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   BINDING         163
FT                   /note="IMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   BINDING         177
FT                   /note="IMP; shared with dimeric partner"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   BINDING         256
FT                   /note="IMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   BINDING         271
FT                   /note="IMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   BINDING         335
FT                   /note="IMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   BINDING         337
FT                   /note="GTP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03126"
FT   VAR_SEQ         1..64
FT                   /note="MSGTRASNDRPPGAGGVKRGRLQQEAAATGSRVTVVLGAQWGDEGKGKVVDL
FT                   LATDADIISRCQ -> MVGRSCGVATQRQGGGQRPTNLALTLSSSPAHSTALPWLPPRS
FT                   LQLLSGHSVPAQPTPHLPSACGGPTRVTLGEERAWRSHGSNAGGHTCLPRRTAGAGSLT
FT                   PGGER (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_008421"
FT   VARIANT         261
FT                   /note="D -> N (in MPD5; decreased protein abundance;
FT                   decreased stability; decreased adenylosuccinate synthase
FT                   activity; dbSNP:rs140614802)"
FT                   /evidence="ECO:0000269|PubMed:26506222"
FT                   /id="VAR_076998"
SQ   SEQUENCE   457 AA;  50208 MW;  387341D49721B2EF CRC64;
     MSGTRASNDR PPGAGGVKRG RLQQEAAATG SRVTVVLGAQ WGDEGKGKVV DLLATDADII
     SRCQGGNNAG HTVVVDGKEY DFHLLPSGII NTKAVSFIGN GVVIHLPGLF EEAEKNEKKG
     LKDWEKRLII SDRAHLVFDF HQAVDGLQEV QRQAQEGKNI GTTKKGIGPT YSSKAARTGL
     RICDLLSDFD EFSSRFKNLA HQHQSMFPTL EIDIEGQLKR LKGFAERIRP MVRDGVYFMY
     EALHGPPKKI LVEGANAALL DIDFGTYPFV TSSNCTVGGV CTGLGIPPQN IGDVYGVVKA
     YTTRVGIGAF PTEQINEIGG LLQTRGHEWG VTTGRKRRCG WLDLMILRYA HMVNGFTALA
     LTKLDILDVL GEVKVGVSYK LNGKRIPYFP ANQEMLQKVE VEYETLPGWK ADTTGARRWE
     DLPPQAQNYI RFVENHVGVA VKWVGVGKSR ESMIQLF
//
